Matching slides 303,780
Current window 199,921-199,950
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

199,921-199,950 of 303,780

filter-aware
02
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
03
The background contains a pattern of A, T, C, G letters, suggesting a focus on genomics or biotechnology.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
04
The chart uses a bar-horizontal format to compare 23andMe's 13.1M data points against other research programs.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Loop · Golden Circle1 hit
05
Uses a quote from Elisabeth Rosenthal to anchor the problem statement.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Beat · Problem1 hit
06
Uses a list of industry-disruptor pairs to build a case for 23andMe's position in healthcare.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
07
The slide uses a timeline-style list to demonstrate regulatory milestones.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Beat · Traction1 hit
08
The slide combines quantitative traction metrics with a qualitative customer story to validate the value proposition.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
09
The slide uses a DNA-themed background with a prominent quote.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the achievement of critical mass at 10M+ genetic profiles.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
14
Uses a flow diagram to show the gap in current healthcare screening criteria.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
17
The slide highlights the value proposition of the premium subscription tier.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
18
The slide features a background pattern of DNA base pairs (A, T, C, G) and a circular '3' icon, suggesting it is the third section of the deck.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
20
The slide uses a gradient background on the left and a bar chart on the right to visualize survey results.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
Uses a before-after-framing structure to contrast current industry standards with the company's value proposition.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
22
The slide uses a process-flow style diagram to show how the combined entities enable six specific service offerings.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
23
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
24
The slide uses a horizontal flow to illustrate integration across the service lifecycle.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The slide features a DNA-themed background with scattered nucleotide letters (A, C, T, G) and a prominent '4' in a circle, likely indicating a section number.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
27
The slide uses a split-screen layout with a white background for data and a magenta background for the thesis statement.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
28
The slide highlights both the breadth of the participant pool and the speed of research execution.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
29
Includes a Manhattan plot visualization and a zoomed-in regional association plot.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
30
The slide uses Manhattan plots to visualize genetic associations over time (2016, 2017, 2021) and a line chart to show the growth of independent hits from 2015 to 2020.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
31
The slide uses a grid of small-multiple charts to demonstrate breadth, with a specific callout for NAFLD at the bottom.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
32
The slide uses Manhattan plots to show genetic associations linked to specific proteins in the TSLP pathway.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
33
The slide uses a timeline-style bar chart to show clinical progress for two lead assets and a summary metric for early-stage programs.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
34
The slide uses a heatmap to demonstrate how genetic signals correlate with various phenotypes, specifically highlighting a rare disease.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
35
The slide uses a funnel metaphor to show the refinement of data into drug targets.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
36
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
37
The slide uses a three-step process flow (Market -> Methodology -> Discovery).23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
38
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit